Immunotherapy Drugs Market - By Type (Monoclonal Antibodies, Checkpoint Inhibitors, Interferons & Interleukins, Other Immunotherapies) By Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Other Therapeutic Areas) By End User (Hospitals, Clinics, Other End Users) By Region (North America, Europe, Asia Pacific, Rest of the World) - Industry Analysis, Opportunity and Forecast 2020 To 2027
Published Date: May 2021
No. of Pages: 196
Status: Published
Report Code: ARI100774
Rising adoption of immunotherapy drugs from individuals suffering from chronical diseases such as solid tumors is a major factor expected to drive growth of the global market. In addition, increasing government expenditure on development of healthcare infrastructure in order to facilitate healthcare services, coupled with increasing investment by government and private players for development of novel product offerings is another factor expected to further support growth of the global market to certain extent.
Moreover, rising number of cases for autoimmune and inflammatory diseases in hospitals, coupled with increasing adoption of advanced medication for treatment of various diseases by hospitals and clinics are among other factors expected to support growth of the global market to certain extent. In addition, growing public-private partnership for R&D activates and innovative product offerings are another factor expected to further support growth of the global market.
However, high cost of immunotherapy treatment is a major factor expected to hamper growth of the global market over the forecast period. In addition, side-effects of immunotherapy on body is another factor expected to limit growth of the global market to certain extent.
The major players in the global immunotherapy drugs market are F. Hoffmann-La Roche Ltd. (UK), Pfizer Inc. (US), Merck & Co (US), Novartis International AG (UK), Johnson & Johnson (US), Sanofi (France), GlaxoSmithKline Plc (UK), Amgen Inc. (US), AbbVie Inc. (US), BoehringerIngelheim (Germany), AstraZeneca (UK), and Immatics Biotechnologies (Germany), BioNTech SE, Genmab, Gilead Sciences, NBE Therapeutics, Teva Pharmaceuticals, Bayer, and Bristol-Myers Squibb.
Analyst Commentary
The future of Immunotherapy drugs lies in the emergence of anticancer agents that suppress the immune checkpoints. The anticancer agents have transformed the field of oncology, showing robust responses and improvements in melanoma, renal cell carcinoma, head or neck squamous cell carcinoma, urothelial bladder cancer, and non–small cell lung cancer.
On the basis of therapy area, the monoclonal antibodies segment accounted for the largest share of the global immunotherapy drugs market in 2019. This large share can be attributed to their high specificity and fewer side-effects, increasing focus on personalized medicines, initiatives by industry players, and the rising target disease incidence and patient pool.
On the basis of therapeutic area, Cancer accounted for the largest share of the global immunotherapy drugs market, by therapeutic area, in 2019. The large share of this segment can be attributed to the growing prevalence of cancer, rising research activity in this area, and reimbursement coverage for immunotherapy for oncology.
On the basis of end user, Hospitals accounted for the largest share of the global market in 2019. This segment is also estimated to grow at the highest CAGR of 12.1% over the forecast period. The large share of this segment can be attributed to the rising spending by hospitals for immunotherapies and the demand for advanced treatments currently only provided by hospitals.
Segmentation
The global immunotherapy drugs market is segmented based on type, therapy area of drugs, end users and region. Based on therapy area, it is divided into cancer, autoimmune & inflammatory diseases, infectious diseases, and others.. Based on therapy area of drugs, it is classified into monoclonal antibodies, adult vaccines, checkpoint inhibitors, interferons alpha & beta, interleukins, and others. On the basis of end users the market is bifurcated into hospitals, clinics and others.
Regional Analysis
Geographically, the global immunotherapy drugs market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the immunotherapy drugs market in 2019. The large share of this region in the global market can be attributed to the increasing prevalence of cancer and autoimmune diseases, rising demand for safer cancer therapies, increasing number of approvals from the FDA, and the introduction of favorable reimbursement policies.
The market in North America is expected to dominate in the global market in terms of revenue and is expected to continue its dominance over the forecast period. This can be attributed to well-developed healthcare infrastructure, favorable reimbursement policies, and presence of major players operating in the countries in this region. In addition, rising merger and acquisition activities for R&D activates is expected to further support growth of the global market in this region over the forecast period.
The market in Asia Pacific is expected to witness faster growth, owing to increasing government expenditure on pharmaceutical sector, rising adoption immunotherapy drugs by number of hospitals, and presence of prominent players operating in the emerging economies in this region.
The market in Latin America is anticipated to witness moderate growth, this growth can be attributed to increasing presence of major pharmaceutical manufacturers in the countries in this region.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Immunotherapy Drugs Market
Chapter 5. Global Immunotherapy Drugs Market Overview, By Type, 2015 – 2027 (USD Billion)
5.1. Global Immunotherapy Drugs Market Share, By Type, 2020 & 2027 (%)
5.1.1. Monoclonal Antibodies
5.1.1.1. Market Size and Projections,2015 – 2027 (USD Billion)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
5.1.2. Checkpoint Inhibitors
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
5.1.3. Interferons & Interleukins
5.1.3.1. Market Size and Projections, 2015 - 2027 (USD Billion)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
5.1.4. Other Immunotherapies
5.1.4.1. Market Size and Projections, 2015 - 2027 (USD Billion)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
Chapter 6. Global Immunotherapy Drugs Market Overview, By Therapy Area, 2015 – 2027 (USD Billion)
6.1. Global Immunotherapy Drugs Market Share, By Therapy Area, 2020 & 2027 (%)
6.1.1. Cancer
6.1.1.1. Market Size and Projections,2015 – 2027 (USD Billion)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
6.1.2. Autoimmune & Inflammatory Diseases
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
6.1.3. Infectious Diseases
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
6.1.4. Other Therapeutic Areas
6.1.4.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
Chapter 7. Global Immunotherapy Drugs Market Overview, By End User, 2015 – 2027 (USD Billion)
7.1. Global Immunotherapy Drugs Market Share, By End User, 2020 & 2027 (%)
7.1.1. Hospitals
7.1.1.1. Market Size and Projections,2015 – 2027 (USD Billion)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
7.1.2. Clinics
7.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
7.1.3. Other End User
7.1.3.1. Market Size and Projections, 2015 - 2027 (USD Billion)
7.1.3.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
Chapter 8. Global Immunotherapy Drugs Market Overview, By Geography, 2015 - 2027 (USD Billion)
8.1. Global Immunotherapy Drugs Market Share, By Geography, 2015 - 2027(USD Billion)
8.1.1. Market Size and projections, by Countries, 2015 - 2027 (USD Billion)
8.1.2. Market Share and CAGR Comparison, by Countries, 2020 (%)
Chapter 9. North America Immunotherapy Drugs Market Overview, By Countries, 2015 - 2027(USD Billion)
9.1. North America Immunotherapy Drugs Market Overview, 2020 & 2027 (%)
9.1.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.2. North America Immunotherapy Drugs Market Overview, By Type, 2015 - 2027(USD Billion)
9.1.3. North America Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027(USD Billion)
9.1.4. North America Immunotherapy Drugs Market Overview, By End User, 2015 - 2027(USD Billion)
9.1.5. North America Immunotherapy Drugs Market Overview, By Countries, 2015 - 2027 (USD Billion)
9.1.5.1. U.S. Immunotherapy Drugs Market Overview, 2015 - 2027 (USD Billion)
9.1.5.1.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.5.1.2. U.S. Immunotherapy Drugs Market Overview, By Type, 2015 - 2027 (USD Billion)
9.1.5.1.3. U.S. Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027 (USD Billion)
9.1.5.1.4. U.S. Immunotherapy Drugs Market Overview, By End User, 2015 - 2027 (USD Billion)
9.1.5.2. Canada Immunotherapy Drugs Market Overview, 2015 - 2027 (USD Billion)
9.1.5.2.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.5.2.2. Canada Immunotherapy Drugs Market Overview, By Type, 2015 - 2027 (USD Billion)
9.1.5.2.3. Canada Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027 (USD Billion)
9.1.5.2.4. Canada Immunotherapy Drugs Market Overview, By End User, 2015 - 2027 (USD Billion)
9.1.5.3. Mexico Immunotherapy Drugs Market Overview, 2015 - 2027 (USD Billion)
9.1.5.3.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.5.3.2. Mexico Immunotherapy Drugs Market Overview, By Type, 2015 - 2027 (USD Billion)
9.1.5.3.3. Mexico Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027 (USD Billion)
Chapter 10. Europe Immunotherapy Drugs Market Overview, By Countries, 2015 - 2027(USD Billion)
10.1. Europe Immunotherapy Drugs Market Overview, 2020 & 2027 (%)
10.1.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.2. Europe Immunotherapy Drugs Market Overview, By Type, 2015 - 2027 (USD Billion)
10.1.3. Europe Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027 (USD Billion)
10.1.4. Europe Immunotherapy Drugs Market Overview, By End User, 2015 - 2027 (USD Billion)
10.1.5. Europe Immunotherapy Drugs Market Overview, By Countries, 2015 - 2027 (USD Billion)
10.1.5.1. Germany
10.1.5.1.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.5.1.2. Germany Immunotherapy Drugs Market Overview, By Type, 2015 - 2027 (USD Billion)
10.1.5.1.3. Germany Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027 (USD Billion)
10.1.5.1.4. Germany Immunotherapy Drugs Market Overview, By End User, 2015 - 2027 (USD Billion)
10.1.5.1.5. Market size and projections, 2015 - 2027 (USD Billion)
10.1.5.1.6. France Immunotherapy Drugs Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.5.1.7. France Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027(USD Billion)
10.1.5.1.8. France Immunotherapy Drugs Market Overview, By End User, 2015 - 2027(USD Billion)
10.1.5.2. UK
10.1.5.2.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.5.2.2. UK Immunotherapy Drugs Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.5.2.3. UK Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027(USD Billion)
10.1.5.2.4. UK Immunotherapy Drugs Market Overview, By End User, 2015 - 2027(USD Billion)
10.1.5.3. Italy
10.1.5.3.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.5.3.2. Italy Immunotherapy Drugs Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.5.3.3. Italy Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027(USD Billion)
10.1.5.3.4. Italy Immunotherapy Drugs Market Overview, By End User, 2015 - 2027(USD Billion)
10.1.5.4. Spain
10.1.5.4.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.5.4.2. Spain Immunotherapy Drugs Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.5.4.3. Italy Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027(USD Billion)
10.1.5.4.4. Italy Immunotherapy Drugs Market Overview, By End User, 2015 - 2027(USD Billion)
10.1.5.5. Rest of Europe
10.1.5.5.1. Market size and projections, 2015 – 2025
10.1.5.5.2. Rest of Europe Immunotherapy Drugs Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.5.5.3. Rest of Europe Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027(USD Billion)
10.1.5.5.4. Rest of Europe Immunotherapy Drugs Market Overview, By End User, 2015 - 2027(USD Billion)
Chapter 11. Asia Pacific Immunotherapy Drugs Market Overview, By Countries, 2015 - 2027(USD Billion)
11.1. Asia Pacific Immunotherapy Drugs Market Overview, 2020 & 2027(%)
11.1.1. Market size and projections, 2015 - 2027(USD Billion)
11.1.2. Asia Pacific Immunotherapy Drugs Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.3. Asia Pacific Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027(USD Billion)
11.1.4. Asia Pacific Immunotherapy Drugs Market Overview, By End User, 2015 - 2027(USD Billion)
11.1.5. Asia Pacific Immunotherapy Drugs Market Overview, By Countries, 2015 - 2027(USD Billion)
11.1.5.1. India
11.1.5.1.1. Market size and projections, 2015 - 2027(USD Billion)
11.1.5.1.2. India Immunotherapy Drugs Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.5.1.3. India Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027(USD Billion)
11.1.5.1.4. India Immunotherapy Drugs Market Overview, By End User, 2015 - 2027(USD Billion)
11.1.5.2. China
11.1.5.2.1. Market size and projections, 2015 - 2027(USD Billion)
11.1.5.2.2. China Immunotherapy Drugs Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.5.2.3. China Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027(USD Billion)
11.1.5.2.4. China Immunotherapy Drugs Market Overview, By End User, 2015 - 2027(USD Billion)
11.1.5.3. Japan
11.1.5.3.1. Market size and projections, 2015 - 2027(USD Billion)
11.1.5.3.2. Japan Immunotherapy Drugs Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.5.3.3. Japan Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027(USD Billion)
11.1.5.3.4. Japan Immunotherapy Drugs Market Overview, By End User, 2015 - 2027(USD Billion)
11.1.5.4. South Korea
11.1.5.4.1. Market size and projections, 2015 - 2027(USD Billion)
11.1.5.4.2. South Korea Immunotherapy Drugs Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.5.4.3. South Korea Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027(USD Billion)
11.1.5.4.4. South Korea Immunotherapy Drugs Market Overview, By End User, 2015 - 2027(USD Billion)
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market size and projections, 2015 - 2027(USD Billion)
11.1.5.5.2. Rest of Asia Pacific Immunotherapy Drugs Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.5.5.3. Rest of Asia Pacific Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027(USD Billion)
11.1.5.5.4. Rest of Asia Pacific Immunotherapy Drugs Market Overview, By End User, 2015 - 2027(USD Billion)
Chapter 12. Middle East & Africa Immunotherapy Drugs Market Overview, By Countries, 2015 - 2027(USD Billion)
12.1. Middle East & Africa Immunotherapy Drugs Market Overview, 2015 - 2027(USD Billion)
12.1.1. Market size and projections, 2015 - 2027(USD Billion)
12.1.2. Middle East & Africa Immunotherapy Drugs Market Overview, By Type, 2015 - 2027(USD Billion)
12.1.3. Middle East & Africa Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027(USD Billion)
12.1.4. Middle East & Africa Immunotherapy Drugs Market Overview, By End User, 2015 - 2027(USD Billion)
12.1.5. Middle East & Africa Immunotherapy Drugs Market Overview, By Countries, 2015 - 2027(USD Billion)
12.1.5.1. GCC
12.1.5.1.1. Market size and projections, 2015 - 2027(USD Billion)
12.1.5.1.2. GCC Immunotherapy Drugs Market Overview, By Type, 2015 - 2027(USD Billion)
12.1.5.1.3. GCC Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027(USD Billion)
12.1.5.1.4. GCC Immunotherapy Drugs Market Overview, By End User, 2015 - 2027(USD Billion)
12.1.5.1.5. Market size and projections, 2015 - 2027(USD Billion)
12.1.5.1.6. South Africa Immunotherapy Drugs Market Overview, By Type, 2015 - 2027(USD Billion)
12.1.5.1.7. South Africa Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027(USD Billion)
12.1.5.1.8. South Africa Immunotherapy Drugs Market Overview, By End User, 2015 - 2027(USD Billion)
12.1.5.2. Rest of Middle East & Africa
12.1.5.2.1. Market size and projections, 2015 - 2027(USD Billion)
12.1.5.2.2. Rest of Middle East & Africa Immunotherapy Drugs Market Overview, By Type, 2015 - 2027(USD Billion)
12.1.5.2.3. Rest of Middle East & Africa Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027(USD Billion)
12.1.5.2.4. Rest of Middle East & Africa Immunotherapy Drugs Market Overview, By End User, 2015 - 2027(USD Billion)
Chapter 13. South America Immunotherapy Drugs Market Overview, By Countries, 2015 - 2027(USD Billion)
13.1. South America Immunotherapy Drugs Market Overview, 2015 - 2027(USD Billion)
13.1.1. Market size and projections, 2015 - 2027(USD Billion)
13.1.2. South America Immunotherapy Drugs Market Overview, By Type 2015 - 2027(USD Billion)
13.1.3. South America Immunotherapy Drugs Market Overview, By Therapy Area 2015 - 2027(USD Billion)
13.1.4. South America Immunotherapy Drugs Market Overview, By End User 2015 - 2027(USD Billion)
13.1.5. South America Immunotherapy Drugs Market Overview, By Countries, 2015- 2026(USD Billion)
13.1.6. Brazil
13.1.6.1. Market size and projections, 2015 - 2027(USD Billion)
13.1.6.2. Brazil Immunotherapy Drugs Market Overview, By Type, 2015 - 2027(USD Billion)
13.1.6.3. Brazil Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027(USD Billion)
13.1.6.4. Brazil Immunotherapy Drugs Market Overview, By End User, 2015 - 2027(USD Billion)
13.1.7. Argentina
13.1.7.1. Market size and projections, 2015 - 2027(USD Billion)
13.1.7.2. Argentina Immunotherapy Drugs Market Overview, By Type, 2015 - 2027(USD Billion)
13.1.7.3. Argentina Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027(USD Billion)
13.1.7.4. Argentina Immunotherapy Drugs Market Overview, By End User, 2015 - 2027(USD Billion)
13.1.8. Rest of South America
13.1.8.1. Market size and projections, 2015 – 2027
13.1.8.2. Rest of South America Immunotherapy Drugs Market Overview, By Type, 2015 - 2027(USD Billion)
13.1.8.3. Rest of South America Immunotherapy Drugs Market Overview, By Therapy Area, 2015 - 2027(USD Billion)
13.1.8.4. Rest of South America Immunotherapy Drugs Market Overview, By End User, 2015 - 2027(USD Billion)
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2020
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New product development
Chapter 15. Key Vendor Analysis
15.1. PFIZER INC.
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Product Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Merck & Co Inc.
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Product Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. Johnson & Johnson
15.4. Sanofi
15.5. Amgen Inc.
15.6. Others
Chapter 16. Immunotherapy Drugs Market Cost Analysis
16.1. Key Raw Materials Analysis
16.1.1. Key Raw Materials
16.1.2. Price Trend of Immunotherapy Drugs Key Raw Materials
16.1.3. Key Suppliers of Raw Materials
16.1.4. Market Concentration Rate of Raw Materials
Chapter 17. Industrial Chain, Sourcing Strategy and Downstream Buyers
17.1. Industrial Chain Analysis
17.2. Upstream Raw Materials Sourcing
17.3. Raw Materials Sources of Immunotherapy Drugs Major Manufacturers in 2020
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Technology Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Technology Progress in Related Industry
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Immunotherapy Drugs Market share, By Type, 2020 & 2027 (%)
10. Global Immunotherapy Drugs Market, by Monoclonal Antibodies, By Type, 2015 - 2027(USD Billion)
11. Global Immunotherapy Drugs Market, by Checkpoint Inhibitors, By Type, 2015 - 2027(USD Billion)
12. Global Immunotherapy Drugs Market, by Interferons & Interleukins, By Type, 2015 - 2027(USD Billion)
13. Global Immunotherapy Drugs Market, by Other Immunotherapies, By Type, 2015 - 2027(USD Billion)
14. Global Immunotherapy Drugs Market share, By Therapy Area, 2020 & 2027 (%)
15. Global Immunotherapy Drugs Market, by Cancer, By Therapy Area, 2015 - 2027(USD Billion)
16. Global Immunotherapy Drugs Market, by Autoimmune & Inflammatory Diseases, By Therapy Area, 2015 - 2027(USD Billion)
17. Global Immunotherapy Drugs Market, by Infectious Disease, By Therapy Area, 2015 - 2027(USD Billion)
18. Global Immunotherapy Drugs Market, by Other Therapeutic Areas, By Therapy Area, 2015 - 2027(USD Billion)
19. Global Immunotherapy Drugs Market share, By End User, 2020 & 2027 (%)
20. Global Immunotherapy Drugs Market, by Hospitals, By End User, 2015 - 2027(USD Billion)
21. Global Immunotherapy Drugs Market, by Clinics, By End User, 2015 - 2027(USD Billion)
22. Global Immunotherapy Drugs Market, by Other end users, By End User, 2015 - 2027(USD Billion)
23. Global Immunotherapy Drugs Market share, by region, 2020 & 2027 (%)
24. North America Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
25. North America Immunotherapy Drugs Market share, by Countries, 2020 & 2027 (%)
26. U.S. Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
27. Canada Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
28. Europe Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
29. Europe Immunotherapy Drugs Market share, by Countries, 2020 & 2027 (%)
30. Spain Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
31. UK Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
32. Italy Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
33. Germany Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
34. France Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
35. Rest of Europe Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
36. Asia-Pacific Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
37. Asia-Pacific Immunotherapy Drugs Market share, by Countries, 2020 & 2027 (%)
38. China Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
39. India Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
40. Australia Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
41. Japan Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
42. Rest of Asia-Pacific Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
43. Middle East & Africa Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
44. Middle East & Africa Immunotherapy Drugs Market share, by Countries, 2020 & 2027 (%)
45. GCC Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
46. South Africa Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
47. Rest Of Middle East & Africa Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
48. South America Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
49. Brazil Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
50. Mexico Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
51. Argentina Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
52. Rest of South America Immunotherapy Drugs Market, 2020 - 2027(USD Billion)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Immunotherapy Drugs Market, 2015-2027(USD Billion)
4. Global Immunotherapy Drugs Market requirement, by country, 2015-2027,(USD Billion)
5. North America Immunotherapy Drugs Market, By Type, 2015-2027(USD Billion)
6. North America Immunotherapy Drugs Market, By Therapy Area, 2015-2027(USD Billion)
7. North America Immunotherapy Drugs Market, By End User, 2015-2027(USD Billion)
8. Europe Immunotherapy Drugs Market, By Type, 2015-2027(USD Billion)
9. Europe Immunotherapy Drugs Market, By Therapy Area, 2015-2027(USD Billion)
10. Europe Immunotherapy Drugs Market, By End User, 2015-2027(USD Billion)
11. Asia Pacific Immunotherapy Drugs Market, By Type, 2015-2027(USD Billion)
12. Asia Pacific Immunotherapy Drugs Market, By Therapy Area, 2015-2027(USD Billion)
13. Asia Pacific Immunotherapy Drugs Market, By End User, 2015-2027(USD Billion)
14. Middle East & Africa Immunotherapy Drugs Market, By Type, 2015-2027(USD Billion)
15. Middle East & Africa Immunotherapy Drugs Market, By Therapy Area, 2015-2027(USD Billion)
16. Middle East & Africa Immunotherapy Drugs Market, By End User, 2015-2027(USD Billion)
17. South America Immunotherapy Drugs Market, By Type, 2015-2027(USD Billion)
18. South America Immunotherapy Drugs Market, By Therapy Area, 2015-2027(USD Billion)
19. South America Immunotherapy Drugs Market, By End User, 2015-2027(USD Billion)
20. Global Immunotherapy Drugs Market, Company Market Share, 2020 (%)
21. PFIZER INC.: Product Benchmarking
22. PFIZER INC.: Financial Performance
23. Merck & Co Inc.: Product Benchmarking
24. Merck & Co Inc.: Financial Performance
25. Johnson & Johnson: Product Benchmarking
26. Johnson & Johnson: Financial Performance
27. Sanofi: Product Benchmarking
28. Sanofi: Financial Performance
29. Amgen Inc.: Product Benchmarking
30. Amgen Inc.: Financial Performance
The Leading Key Players in Immunotherapy Drugs Market
F. Hoffmann-La Roche Ltd. (UK)
Pfizer Inc. (US)
Merck & Co (US)
Novartis International AG (UK)
Johnson & Johnson (US)
Sanofi (France)
GlaxoSmithKline Plc (UK)
Amgen Inc. (US)
AbbVie Inc. (US)
BoehringerIngelheim (Germany)
AstraZeneca (UK)
Immatics Biotechnologies (Germany)
BioNTech SE
Genmab
Gilead Sciences
NBE Therapeutics
Teva Pharmaceuticals
Bayer
Bristol-Myers Squibb
